<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0013">
 <label>13.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Gane</surname>
   <given-names>E</given-names>
  </string-name>, 
  <string-name>
   <surname>Poordad</surname>
   <given-names>F</given-names>
  </string-name>, 
  <string-name>
   <surname>Wang</surname>
   <given-names>S</given-names>
  </string-name>, et al. 
  <article-title>High efficacy of ABT-493 and ABT-530 treatment in patients with HCV genotype 1 or 3 infection and compensated cirrhosis</article-title>. 
  <source>
   <italic toggle="yes">Gastroenterology</italic>
  </source>. 
  <year>2016</year>;
  <volume>151</volume>(
  <issue>4</issue>):
  <fpage>651</fpage>â€“
  <lpage>659.e651</lpage>. doi:
  <pub-id pub-id-type="doi">10.1053/j.gastro.2016.07.020</pub-id>
  <pub-id pub-id-type="pmid">27456384</pub-id>
 </mixed-citation>
</ref>
